{
    "xml": "<topic id=\"PHP33535\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/nalmefene\" basename=\"nalmefene\" title=\"NALMEFENE\">\n<title>NALMEFENE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_1256\" namespace=\"/interactions/list-of-drug-interactions/nalmefene\">Nalmefene</xref>\n</p>\n<data name=\"vtmid\">22404211000001106</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_441568498\" title=\"Opioid receptor antagonists\">Opioid receptor antagonists</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP70712\" outputclass=\"indicationsAndDose\" rev=\"1.19\" parent=\"/drugs/nalmefene\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Reduction of alcohol consumption in patients with alcohol dependence who have a high drinking risk level without physical withdrawal symptoms, and who do not require immediate detoxification</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>18&#8239;mg daily if required, taken on each day there is a risk of drinking alcohol, preferably taken 1&#8211;2 hours before the anticipated time of drinking, if a dose has not been taken before drinking alcohol, 1 dose should be taken as soon as possible; maximum 18&#8239;mg per day.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71610\" outputclass=\"contraindications\" rev=\"1.7\" parent=\"/drugs/nalmefene\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Recent history of acute alcohol withdrawal syndrome</ph>; <ph outputclass=\"contraindication\">recent or current opioid use</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP72192\" outputclass=\"cautions\" rev=\"1.10\" parent=\"/drugs/nalmefene\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Continued treatment for more than 1 year</ph>; <ph outputclass=\"caution\">history of seizure disorders (including alcohol withdrawal seizures)</ph>; <ph outputclass=\"caution\">psychiatric illness</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70607\" outputclass=\"interactions\" rev=\"1.11\" parent=\"/drugs/nalmefene\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (nalmefene).</p>\n<p>Avoid concomitant use of opioids&#8212;discontinue treatment 1 week before anticipated use of opioids; if emergency analgesia is required during treatment, an increased dose of opioid analgesic may be necessary (monitor for opioid intoxication).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP69679\" outputclass=\"sideEffects\" rev=\"1.7\" parent=\"/drugs/nalmefene\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Confusion</ph>; <ph outputclass=\"sideEffect\">decreased appetite</ph>; <ph outputclass=\"sideEffect\">decreased libido</ph>; <ph outputclass=\"sideEffect\">disturbance in attention</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">dry mouth</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">hyperhidrosis</ph>; <ph outputclass=\"sideEffect\">hypoaesthesia</ph>; <ph outputclass=\"sideEffect\">malaise</ph>; <ph outputclass=\"sideEffect\">muscle spasms</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">palpitation</ph>; <ph outputclass=\"sideEffect\">paraesthesia</ph>; <ph outputclass=\"sideEffect\">restlessness</ph>; <ph outputclass=\"sideEffect\">sleep disorders</ph>; <ph outputclass=\"sideEffect\">somnolence</ph>; <ph outputclass=\"sideEffect\">tachycardia</ph>; <ph outputclass=\"sideEffect\">tremor</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>; <ph outputclass=\"sideEffect\">weight loss</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Dissociation</ph>; <ph outputclass=\"sideEffect\">hallucinations</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70447\" outputclass=\"pregnancy\" parent=\"/drugs/nalmefene\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid&#8212;toxicity in <i>animal</i> studies.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP72432\" outputclass=\"breastFeeding\" parent=\"/drugs/nalmefene\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid&#8212;present in milk in <i>animal</i> studies.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70977\" outputclass=\"hepaticImpairment\" parent=\"/drugs/nalmefene\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution&#8212;avoid in severe impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70036\" outputclass=\"renalImpairment\" parent=\"/drugs/nalmefene\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution&#8212;avoid in severe impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP69877\" outputclass=\"preTreatmentScreening\" rev=\"1.8\" parent=\"/drugs/nalmefene\">\n<title>Pre-treatment screening</title>\n<body>\n<section>\n<sectiondiv>\n<p>Before initiating treatment, prescribers should evaluate the patient&#8217;s clinical status, alcohol dependence, and level of alcohol consumption. Nalmefene should only be prescribed for patients who continue to have a high drinking risk level two weeks after the initial assessment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP68964\" outputclass=\"monitoringRequirements\" parent=\"/drugs/nalmefene\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>During treatment, patients should be monitored regularly and the need for continued treatment assessed.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP68389\" outputclass=\"nationalFunding\" rev=\"1.17\" parent=\"/drugs/nalmefene\">\n<title>National funding/access decisions</title>\n<body>\r\n<section>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisals\">\r\n<p outputclass=\"title\">NICE technology appraisals (TAs)</p>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisal\">\r\n<p outputclass=\"fundingIdentifier\">NICE TA325</p>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Nalmefene for reducing alcohol consumption in people with alcohol dependence (November 2014)</p>\r\n<p>Nalmefene is recommended within its marketing authorisation, as an option for reducing alcohol consumption, for patients with alcohol dependence:</p>\r\n<ul>\r\n<li>who have a high drinking risk level (defined as alcohol consumption of more than 60&#8239;g per day for men and more than 40&#8239;g per day for women, according to the World Health Organization's drinking risk levels) without physical withdrawal symptoms, <b>and</b>\r\n</li>\r\n<li>who do not require immediate detoxification.</li>\r\n</ul>\r\n<p>The marketing authorisation states that nalmefene should:</p>\r\n<ul>\r\n<li>only be prescribed in conjunction with continuous psychosocial support focused on treatment adherence and reducing alcohol consumption, <b>and</b>\r\n</li>\r\n<li>be initiated only in patients who continue to have a high drinking risk level 2 weeks after initial assessment.</li>\r\n</ul>\n</sectiondiv>\n<xref format=\"html\" href=\"http://www.nice.org.uk/TA325\">www.nice.org.uk/TA325</xref>\n</sectiondiv>\n</sectiondiv>\r\n </section>\r\n\r\n</body>\n</topic>\n<topic id=\"PHP33535-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/nalmefene\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76732\" title=\"Tablet\" namespace=\"/drugs/nalmefene/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78560\" namespace=\"/treatment-summaries/substance-dependence\" title=\"Substance dependence\" count=\"3\" rel=\"backlink\">Substance dependence</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1256\" namespace=\"/interactions/list-of-drug-interactions/nalmefene\" title=\"Nalmefene\" count=\"1\" rel=\"link\">Nalmefene</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76732\" namespace=\"/drugs/nalmefene/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP33535",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/nalmefene",
    "basename": "nalmefene",
    "title": "NALMEFENE",
    "interactants": [
        {
            "id": "bnf_int_1256",
            "label": "Nalmefene"
        }
    ],
    "vtmid": "22404211000001106",
    "drugClassification": [
        "Opioid receptor antagonists"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Reduction of alcohol consumption in patients with alcohol dependence who have a high drinking risk level without physical withdrawal symptoms, and who do not require immediate detoxification",
                        "html": "Reduction of alcohol consumption in patients with alcohol dependence who have a high drinking risk level without physical withdrawal symptoms, and who do not require immediate detoxification"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "18 mg daily if required, taken on each day there is a risk of drinking alcohol, preferably taken 1&#8211;2 hours before the anticipated time of drinking, if a dose has not been taken before drinking alcohol, 1 dose should be taken as soon as possible; maximum 18 mg per day.",
                        "html": "<p>18&#8239;mg daily if required, taken on each day there is a risk of drinking alcohol, preferably taken 1&#8211;2 hours before the anticipated time of drinking, if a dose has not been taken before drinking alcohol, 1 dose should be taken as soon as possible; maximum 18&#8239;mg per day.</p>"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Recent history of acute alcohol withdrawal syndrome",
                "html": "Recent history of acute alcohol withdrawal syndrome"
            },
            {
                "type": "contraindications",
                "textContent": "recent or current opioid use",
                "html": "recent or current opioid use"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Continued treatment for more than 1 year",
                "html": "Continued treatment for more than 1 year"
            },
            {
                "type": "cautions",
                "textContent": "history of seizure disorders (including alcohol withdrawal seizures)",
                "html": "history of seizure disorders (including alcohol withdrawal seizures)"
            },
            {
                "type": "cautions",
                "textContent": "psychiatric illness",
                "html": "psychiatric illness"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (nalmefene).\n\nAvoid concomitant use of opioids&#8212;discontinue treatment 1 week before anticipated use of opioids; if emergency analgesia is required during treatment, an increased dose of opioid analgesic may be necessary (monitor for opioid intoxication).",
                "html": "<p>Appendix 1 (nalmefene).</p><p>Avoid concomitant use of opioids&#8212;discontinue treatment 1 week before anticipated use of opioids; if emergency analgesia is required during treatment, an increased dose of opioid analgesic may be necessary (monitor for opioid intoxication).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Confusion",
                        "html": "Confusion",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "decreased appetite",
                        "html": "decreased appetite",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "decreased libido",
                        "html": "decreased libido",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "disturbance in attention",
                        "html": "disturbance in attention",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dry mouth",
                        "html": "dry mouth",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "hyperhidrosis",
                        "html": "hyperhidrosis",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "hypoaesthesia",
                        "html": "hypoaesthesia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "malaise",
                        "html": "malaise",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "muscle spasms",
                        "html": "muscle spasms",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "palpitation",
                        "html": "palpitation",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "paraesthesia",
                        "html": "paraesthesia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "restlessness",
                        "html": "restlessness",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "sleep disorders",
                        "html": "sleep disorders",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "somnolence",
                        "html": "somnolence",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "tachycardia",
                        "html": "tachycardia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "tremor",
                        "html": "tremor",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "weight loss",
                        "html": "weight loss",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Dissociation",
                        "html": "Dissociation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hallucinations",
                        "html": "hallucinations",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid&#8212;toxicity in animal studies.",
                "html": "<p>Manufacturer advises avoid&#8212;toxicity in <i>animal</i> studies.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid&#8212;present in milk in animal studies.",
                "html": "<p>Manufacturer advises avoid&#8212;present in milk in <i>animal</i> studies.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution&#8212;avoid in severe impairment.",
                "html": "<p>Use with caution&#8212;avoid in severe impairment.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution&#8212;avoid in severe impairment.",
                "html": "<p>Use with caution&#8212;avoid in severe impairment.</p>"
            }
        ]
    },
    "preTreatmentScreening": {
        "preTreatmentScreening": [
            {
                "type": "preTreatmentScreening",
                "textContent": "Before initiating treatment, prescribers should evaluate the patient&#8217;s clinical status, alcohol dependence, and level of alcohol consumption. Nalmefene should only be prescribed for patients who continue to have a high drinking risk level two weeks after the initial assessment.",
                "html": "<p>Before initiating treatment, prescribers should evaluate the patient&#8217;s clinical status, alcohol dependence, and level of alcohol consumption. Nalmefene should only be prescribed for patients who continue to have a high drinking risk level two weeks after the initial assessment.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "During treatment, patients should be monitored regularly and the need for continued treatment assessed.",
                "html": "<p>During treatment, patients should be monitored regularly and the need for continued treatment assessed.</p>"
            }
        ]
    },
    "nationalFunding": {
        "niceTechnologyAppraisals": [
            {
                "type": "niceTechnologyAppraisals",
                "references": [
                    {
                        "id": "http://www.nice.org.uk/TA325",
                        "label": "www.nice.org.uk/TA325"
                    }
                ],
                "fundingIdentifier": "NICE TA325",
                "textContent": "Nalmefene for reducing alcohol consumption in people with alcohol dependence (November 2014) Nalmefene is recommended within its marketing authorisation, as an option for reducing alcohol consumption, for patients with alcohol dependence: who have a high drinking risk level (defined as alcohol consumption of more than 60 g per day for men and more than 40 g per day for women, according to the World Health Organization's drinking risk levels) without physical withdrawal symptoms, and who do not require immediate detoxification. The marketing authorisation states that nalmefene should: only be prescribed in conjunction with continuous psychosocial support focused on treatment adherence and reducing alcohol consumption, and be initiated only in patients who continue to have a high drinking risk level 2 weeks after initial assessment.\n\nwww.nice.org.uk/TA325",
                "html": "<p outputclass=\"title\">Nalmefene for reducing alcohol consumption in people with alcohol dependence (November 2014)</p> <p>Nalmefene is recommended within its marketing authorisation, as an option for reducing alcohol consumption, for patients with alcohol dependence:</p> <ul> <li>who have a high drinking risk level (defined as alcohol consumption of more than 60&#8239;g per day for men and more than 40&#8239;g per day for women, according to the World Health Organization's drinking risk levels) without physical withdrawal symptoms, <b>and</b> </li> <li>who do not require immediate detoxification.</li> </ul> <p>The marketing authorisation states that nalmefene should:</p> <ul> <li>only be prescribed in conjunction with continuous psychosocial support focused on treatment adherence and reducing alcohol consumption, <b>and</b> </li> <li>be initiated only in patients who continue to have a high drinking risk level 2 weeks after initial assessment.</li> </ul><xref format=\"html\" href=\"http://www.nice.org.uk/TA325\">www.nice.org.uk/TA325</xref>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76732",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78560",
                "label": "Substance dependence",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_1256",
                "label": "Nalmefene",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76732",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}